AbCellera Biologics
ABCL
ABCL
127 hedge funds and large institutions have $279M invested in AbCellera Biologics in 2025 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 32 increasing their positions, 49 reducing their positions, and 28 closing their positions.
Holders
127
Holders Change
-19
Holders Change %
-13.01%
% of All Funds
1.73%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
12
Increased
32
Reduced
49
Closed
28
Calls
$682K
Puts
$927K
Net Calls
-$245K
Net Calls Change
+$82K
Top Buyers
| 1 |
1
UBS AM
Chicago,
Illinois
|
$34.9M |
| 2 |
2
Capital World Investors
Los Angeles,
California
|
$29.8M |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$11.3M |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$4.05M |
| 5 |
5
Renaissance Technologies
New York
|
$6.45M |
